Neuroendoscopic lavage for treatment of intraventricular hemorrhage (IVH) and posthemorrhage hydrocephalus (PHH) among preterm infants

Neuroendoscopic lavage for treatment of intraventricular hemorrhage (IVH) and posthemorrhage hydrocephalus (PHH) among preterm infants: a single-center interventional study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86628725

Enrollment

Registered

2015-11-30

Start date

2015-11-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraventricular hemorrhage (IVH) and posthemorrhagic hydrocephalus (PHH) Circulatory System

Interventions

There is only one treatment arm in this study. With parental consent, eligible infants who are receiving a temporary ventriculosubgaleal shunt or ventricular access device will also receive the endosc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Premature infants with intraventricular hemorrhage (IVH) and posthemorrhagic hydrocephalus (PHH) who are eligible for a ventriculosubgaleal shunt or ventricular access device

Exclusion criteria

Exclusion criteria: Patients not suitable for surgical intervention in the operating room

Design outcomes

Primary

Measure	Time frame
Rate of ventriculoperitoneal (VP) shunt insertion within 12 months of follow-up	—

Secondary

Measure	Time frame
1. Number of overall procedures 2. Rate of infection 3. Rate of supratentorial multiloculated hydrocephalus Outcomes assessed at one year after the procedure	—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026